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Fumonisin B1 (FB1), a mycotoxin produced by Fusarium species is a predominant
Group 2B carcinogen occurring in maize and maize-based poultry feeds. It is shown
to be nephrotoxic, hepatotoxic, neurotoxic, and immunosuppressing in animals. In this
study, we report the ameliorating effects of a probiotic strain, Lactobacillus plantarum
MYS6 on FB1-induced toxicity and oxidative damage in broilers. A 6-week dietary
experiment consisting of 48 broilers was performed in six treatment groups. Probiotic
treatment (109 cells/mL) involved pre-colonization of broilers with L. plantarum MYS6
while co-administration treatment involved supplementation of probiotic and FB1-
contaminated diet (200 mg/Kg feed) simultaneously. At the end of the treatment
period, growth performance, hematology, serum biochemistry, and markers of oxidative
stress in serum and tissue homogenates were evaluated in all the broilers. The
histopathological changes in hepatic and renal tissues were further studied. The
results demonstrated that administration of L. plantarum MYS6 efficiently improved
the feed intake, body weight and feed conversion ratio in broilers. It mitigated the
altered levels of hematological indices such as complete blood count, hemoglobin,
and hematocrit. Serum parameters such as serum glutamic oxaloacetic transaminase,
serum glutamic pyruvic transaminase, creatinine, cholesterol, triglycerides, and albumin
were significantly restored after administering the probiotic in FB1-intoxicated broilers.
Additionally, L. plantarum MYS6 alleviated the levels of oxidative stress markers in
serum and tissue homogenate of liver. The histopathological data of liver and kidney
further substantiated the overall protection offered by L. plantarum MYS6 against
FB1-induced cellular toxicity and organ damage in broilers. Our results indicated that
co-administration of probiotic along with the toxin had better effect in detoxification
compared to its pre-colonization in broilers. Collectively, our study signifies the protective
role of L. plantarum MYS6 in ameliorating the FB1-induced toxicity in the vital organs
and subsequent oxidative stress in broilers. The probiotic L. plantarum MYS6 can further
be formulated into a functional feed owing to its anti-fumonisin attributes and role in
mitigating FB1-induced hepatorenal damage.
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INTRODUCTION
Fumonisin B1 (FB1), a potentially hazardous mycotoxin,
produced mainly by Fusarium verticillioides and F. proliferatum,
is a common contaminant of maize-based poultry feeds
contributing to the unpalatability of feed and reduction
in nutrient quality. It affects the alimentary value and
organoleptic characteristics of feeds resulting in decreased
feed intake and animal performance. FB1 entails the risk of
mycotoxicoses and other major diseases in farm animals such
as poultry (nephrotoxic and immunosuppressing effects), horses
(leukoencephalomalacia), swine (pulmonary edema), cattle etc
(Fandohan et al., 2005). High exposure to FB1 is hepatotoxic,
and also causes lesions in gastrointestinal tract (Escriva et al.,
2015). FB1 has been epidemiologically associated with cancer
in humans and classified as Group 2B carcinogen by the
International Agency for Research on Cancer (International
Agency for Research on Cancer [IARC], 2002). The molecular
aspects of FB1-induced toxicity are poorly understood, however,
the downstream toxic cellular mechanisms of FB1 have been
deduced to be complex involving many molecular sites. Studies
have ascribed FB1-induced toxicity to the structural similarity
between fumonisins and the sphingoid bases (sphinganine
and sphingosine) of sphingolipid layer in cell membrane. FB1
inhibits the synthesis of ceramide by specifically binding to
the sphinganine and sphingosine N-acetyltransferase enzymes
thus deregulating the sphingolipid complex formation (Merrill
et al., 2001; Riley et al., 2001; Enongene et al., 2002). This
leads to the intracellular accumulation of sphingoid bases
which further mediate cytotoxicity, apoptosis, cell proliferation,
carcinogenicity, DNA damage (Riley et al., 2001; Voss et al.,
2007), and oxidative stress (Poersch et al., 2014; Abdellatef
and Khalil, 2016). In addition, Domijan and Abramov (2011)
demonstrated that FB1 inhibited the complex 1 of mitochondrial
electron transport chain in the cell cultures of rat primary
astrocytes and human neuroblastoma (SH-SY5Y). This led to a
reduction in the rate of mitochondrial and cellular respiration,
depolarization of mitochondrial membrane, over production of
reactive oxygen species (ROS) in mitochondria, and deregulation
of calcium signaling.
Safe elimination of fumonisins from feeds and/or poultry
is of paramount importance as the poultry sector suffers great
economic losses due to fumonisins compared to other livestock
industries. The most commonly employed detoxification method
in poultry industry is the use of mycotoxin binders in feed.
Nevertheless, a much promising alternative strategy would be
the use of microorganisms such as lactic acid bacteria (LAB)
having the potential to detoxify fumonisins. LAB constitutes
an important group of probiotic organisms used as dietary
supplements for humans and animals. Probiotic strains of LAB
should be capable of adhering to the host intestinal epithelial
cells and surviving in the gastrointestinal conditions. Beneficial
aspects of probiotic LAB include increased feed conversion
(Cenesiz et al., 2008), enhancement of host immune system,
competitive exclusion of pathogens (Chiu et al., 2007), binding
of toxic compounds (Niderkorn et al., 2007), synthesis of
pathogen inhibitory metabolites (Todorov et al., 2008; Gerez
TABLE 1 | Feed composition of the basal diet during pre-starter, starter, and
finisher adopted in the experiment.
Ingredients Pre-starter (%) Starter (%) Finisher (%)
Maize 55.35 59.08 63.44
Soya meal 35 32.5 27.5
Rice polish 4.8 3 3
Rice bran oil 1 2 3
Limestone powder 1.3 1.14 1.1
Digestible crude protein 0.8 0.64 0.4
Salt 0.42 0.37 0.28
Amino acids 0.51 0.48 0.45
Other supplements 0.82 0.79 0.84
et al., 2013), and mitigation of stress conditions (Poersch et al.,
2014; Abdellatef and Khalil, 2016).
Poultry farming is one of the major agricultural sectors
in India contributing greatly to the economy. The majority
of studies on mycotoxins from India are aflatoxin-oriented,
with less attention being paid to fumonisin B1 contamination
in poultry feeds and their toxicity in broilers. A few studies
from India demonstrated FB1 toxicity in Japanese quail
(Asrani et al., 2006; Sharma et al., 2008). In the present
study, we evaluated the in vivo potential of a probiotic
LAB strain (previously characterized in our laboratory) in
ameliorating the FB1-induced toxicity and oxidative stress in
broilers.
MATERIALS AND METHODS
Chemicals
All the chemicals used in this study were of the highest purity
grade available commercially. Dihydrodichlorofluorescein
diacetate (DCFDA) and 4-(2-hydroxyethyl) 1-piperazine
ethane sulfonic acid (HEPES) were obtained from Sigma
(St. Louis, United States). 2, 4-dinitrophenylhydrazine (DNPH),
homovanillic acid (HVA), thiobarbituric acid (TBA), and
all other chemicals and solvents were purchased from Sisco
Research Laboratories (Mumbai, India). Serum glutamic
oxaloacetic transaminase (SGOT), serum glutamic pyruvic
transaminase (SGPT), albumin, triglycerides, creatinine, and
cholesterol commercial kits were purchased from Swemed
Diagnostics (Bengaluru, India).
Diet Preparation and Probiotic Strain
FB1 test diets were prepared using commercially available
broiler feed (basal diet; Shresta feeds, Bengaluru). The basal
diet composition is given in Table 1. Culture jars containing
1 kg of broiler feed (aw = 1, autoclaved at 121◦C for 20 min)
were inoculated with 20 mL of toxigenic Fusarium verticillioides
MTCC 1848 (106 spores/mL). The jars were shaken thoroughly
to ensure complete dispersal of the fungal spores and incubated
in dark for 45 days at 28◦C ± 2◦C. After incubation, jars were
dried in hot air oven at 60◦C for 8–10 h. The dried feed mixture
was ground in a blender to a fine meal. The finely ground feed
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TABLE 2 | Treatment groups of in vivo study.
Experimental groups Treatment
Control (C) Basal diet + PBS control
Positive Control (TOXB) 200 mg FB1/kg feed + 1.0 g/kg feed toxin binder
Group TOX 200 mg FB1/kg feed
Pre-colonization study
Group LP 109 cells/mL Lactobacillus plantarum MYS6
Group LP+TOX 200 mg FB1/kg feed + 109 cells/mL L. plantarum MYS6
Challenge study
Group TOX_LP 200 mg FB1/kg feed + 109 cells/mL L. plantarum MYS6
mixture (0.4 g) was taken in a sterile amber vial and suspended
in 2.0 mL acetonitrile:water (1:1) and allowed for equilibration
overnight in a gel rocker at 28◦C± 2◦C. The extracts were syringe
filtered using 0.45 µm nylon membrane filters and subjected
to liquid chromatography/mass spectrometry (LC/MS) (Waters
Acquity/ Synapt G2, United States). Chromatographic separation
was achieved on a C18 column maintained at 50◦C. Mobile
phase A was 0.3% formic acid in water (v/v) and acetonitrile
being mobile phase B. The mass spectrometer was operated in
the positive electronspray ionization mode (ESI+). The limit of
detection (LOD) for FB1 was 10 ng/mL and retention time was
found to be 1.77 min. (Deepthi et al., 2016). The cultured broiler
feed was mixed with the basal feed to obtain FB1 treatment
equivalent to the ingestion of diet containing toxin concentration
of 200 mg/kg feed.
The bacterial strain, Lactobacillus plantarum MYS6 (LpMYS6)
which was previously characterized in our laboratory with respect
to its probiotic and antifungal attributes (Deepthi et al., 2016) was
used in this study. The bacterium was cultured in de Man Rogosa
Sharpe (MRS) broth anaerobically at 37◦C for 48 h. Cells were
harvested by centrifugation at 8000 rpm for 10 min, washed thrice
and re-suspended in phosphate buffered saline (PBS, 100 mM, pH
7.4) to a final concentration of 109 cells/mL.
Experimental Design and Treatment
The poultry trial was approved (UOM/IAEC/02/2013) by the
Animal Ethical Committee, Department of Zoology, University
of Mysore, Mysuru.
One-day old, 48 Cobb variety broiler chicks (male 27, female-
21) were used in this study. The 1-day old chicks weighed in a
range from 42 to 46 g and were reared in an environmentally
controlled room for 42 days. Chicks were randomly distributed
into six treatment groups with each treatment having eight
chicks. The experimental design involving six treatment groups
is described in Table 2. The basal diet types included pre-
starter feed (0–7 days), starter feed (8–21 days), and finisher feed
(22–42 days). Initial 1-week of acclimatization period at high
temperature (90◦C) was provided to one-day old chicks followed
by vaccination on day 7. The experiment was performed in two
ways: (a) pre-colonization study which started with the pre-
incubation of LpMYS6 from day 8 followed by supplementation
of FB1-contaminated feed mixture from day 12 and (b) challenge
study involved the co-administration of chicks with LpMYS6 and
FB1-contaminated feed simultaneously from day 12. One mL
(109 cells/mL) of LpMYS6 preparation was administered daily
by oral gavage. The positive control consisted of a commercially
available multi-spectrum mycotoxin binder (Varishta, Bengaluru,
India) that was administered to the chicks from day 12. The
toxin binder (TOXB) was a combination of Picrorhiza kurroa,
activated charcoal, hydrated sodium calcium aluminosilicate
(HSCAS), mannan oligosaccharide (MOS), buffered organic
acids, and antioxidants. The control (C) group was also a negative
control where the chicks were provided with basal diet and
PBS. All the chicks were vaccinated for Newcastle disease and
Infectious Bursal Disease (IBD) on day 7 and day 14, respectively.
Antibiotics and liver stimulants were not supplemented in the
basal diet and the basal feed was free from aflatoxins and other
major mycotoxins. All the treatment groups were provided with
water and basal diet ad libitum.
Broiler Performance and Sampling
To evaluate the influence of FB1 and LpMYS6 on broiler
performance, body weight of each bird was measured at weekly
interval and feed consumption of every pen was monitored
throughout the experimental period. The feed conversion ratio
(FCR) was calculated for each treatment on the basis of unit
feed consumption to unit body weight gain. Treatment groups
were observed daily to record the morbidity/mortality. On the
conclusion of experiment (day 42), broilers were submitted to
pre-slaughter fasting for 18 h. Five birds from each treatment
group were randomly selected, weighed, euthanized by cervical
dislocation and necropsied for the excision of liver and kidney.
Prior to sacrifice, blood samples were collected from the jugular
vein in two sets. One set for hematological study was collected
in the sterile vials containing the anticoagulant citrate dextrose
(ACD) maintained in ice bath. The other set of blood samples
was collected in dry sterile tubes, centrifuged at 5000 rpm for
10 min and the serum was separated and stored at −20◦C until
further use. The excised liver and kidney tissues were blotted
free of blood, rinsed with PBS, weighed and stored at−20◦C
for histopathological studies. The excised liver tissues were
homogenized (10% w/v) in ice-cold potassium phosphate buffer
(100 mM, pH 7.4) and centrifuged at 5000 rpm for 15 min at 4◦C.
The resulting supernatant (total liver homogenate) was stored
at −20◦C for the analysis of different parameters to evaluate
oxidative stress.
Determination of Hematological
Parameters
Citrated blood samples of five birds from each treatment group
were checked for hematological indices using a blood cell counter
(ERMA PCE210, Tokyo, Japan). The following parameters were
examined: hemoglobin (HGB), red blood corpuscles (RBC),
white blood corpuscles (WBC), platelets (PLT), and hematocrit
(HCT).
Determination of Serum Biochemical
Parameters
Serum samples were screened for routine biochemical
parameters such as albumin, triglycerides, creatinine, and
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cholesterol. Liver function was assessed by the activities of serum
glutamic oxaloacetic transaminase (SGOT) and serum glutamic
pyruvic transaminase (SGPT). All the above parameters were
estimated according to the instructions of assay kits (Swemed
Diagnostics, Bengaluru, India) using a versatile biochemistry
analyzer ARTOS-SBPL/418 (Swemed Diagnostics, Bengaluru,
India).
Analysis of Oxidative Stress Markers
Estimation of Reactive Oxygen Species (ROS)
The levels of endogenously generated ROS were measured in
liver homogenate and serum as per the protocol described
by Driver et al. (2000). In this assay, an aliquot of liver
homogenate (20 µL, 0.5 mg protein) was dispensed into
a 96 well microtitre plate containing 170 µL of Locke’s
buffer (154 mM NaCl, 5.6 mM KCl, 3.6 mM NaHCO3,
5 mM HEPES, 10 mM glucose, 2 mM CaCl2, pH 7.4). To
this mixture, 10 µL of DCFDA (10 µM) was added and
incubated at room temperature for 30 min. After incubation,
fluorescence was measured using a multimode plate reader
(Thermo Scientific, United States) with excitation and emission
at 480 nm and 530 nm, respectively. To measure the ROS
levels in serum, the same assay was followed but the liver
homogenate was replaced with 10 µL of serum. Background
fluorescence was corrected by the inclusion of parallel blanks.
A dichlorofluorescein standard curve was used to quantify ROS
levels and the data were expressed as pmol DCF formed per mg
protein.
Estimation of Hydrogen Peroxide Level
Another well-known oxidative stress marker, hydrogen peroxide
(H2O2) was quantified in liver homogenate and serum as per
the method followed by Botsoglou et al. (2010) with minor
modifications. Here, 20 µL (0.5 mg protein) of liver homogenate
was dispensed into 96 well microtitre plate containing HEPES
buffered saline (HBS, 145 mM NaCl, 10 mM HEPES, 10 mM
glucose, 5 mM KCl, 1 mM MgSO4, pH 7.4) and incubated with
100 µM HVA at room temperature for 45 min. After incubation,
reaction mixture was excited at 312 nm and fluorescence was
measured at 420 nm. The H2O2 levels in serum samples were
measured by using 10 µL serum as incubation mixture instead of
liver homogenate. The H2O2 levels were expressed as nmol H2O2
per mg protein.
Assessment of Lipid Peroxidation (LPO)
Lipid peroxidation (LPO) status was assessed in liver
homogenate and serum samples by measuring thiobarbituric
acid reactive substances (TBARS) and was expressed in terms of
malondialdehyde (MDA) content, as described by Ohkawa et al.
(1979). In this assay, tubes containing 1.5 mL acetic acid (20%
v/v, pH 3.5), 0.2 mL SDS (8% w/v), 1.5 mL TBA (0.8% w/v) were
added with 200 µL of test sample (liver homogenate/serum).
The reaction mixture was incubated in a boiling water bath for
45 min. After cooling to room temperature, 3 mL of butanol
was added to extract adducts formed and were centrifuged at
2000 rpm for 10 min. The absorbance was measured in the
supernatant at 532 nm and results were expressed in terms of
malondialdehyde equivalents as nmol MDA formed per mg
protein.
Measurement of Protein Carbonyl Content (PCC)
Protein carbonyl content (PCC) was estimated in the liver
homogenate and serum samples using DNPH following the
method described by Levine et al. (1990). Two hundred microliter
of sample (liver homogenate/serum; 0.5–1 mg protein) was added
into eppendorf tube containing 500 µL of 10 mM DNPH in 2 N
HCl and incubated at room temperature for 1 h with intermittent
shaking. Corresponding blank was maintained by adding only
2 N HCl to the sample. After incubation, 500 µL 20% TCA
was added to the mixture to precipitate proteins followed by
centrifugation at 5000 rpm for 10 min. The precipitate was
washed twice with acetone and finally suspended in 1 mL of Tris
buffer (20 mM, pH 7.4 containing 140 mM NaCl and 2% SDS
w/v), vortexed and incubated overnight at 4◦C. The absorbance
of the mixture was read at 360 nm and expressed as nmol of
carbonyl groups per mg protein.
Histopathology
The formalin-fixed tissue samples of liver and kidney were
processed routinely, sectioned at 4–5 µm thickness, stained with
hematoxylin-eosin dye and observed and photographed using
Olympus Bx41 microscope equipped with ProgRes CT3 camera
(Tokyo, Japan).
Protein Estimation
The protein concentration of liver homogenate was estimated by
the protocol of Lowry et al. (1951) using bovine serum albumin
(BSA) as the standard.
Statistical Analysis
The data obtained in this study are the mean of five
determinations expressed as mean ± SEM and analyzed
by one-way analysis of variance (ANOVA) followed by
Bonferroni’s post hoc test for multiple comparison, with following
probability ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001
to be considered statistically significant. The graphs were
drawn using GraphPad Prism version 5.03 software (GraphPad
Software Inc.).
RESULTS
Growth Performance
On completion of 42 days of feeding experiment, broilers
treated with only FB1-contaminated diet (TOX) showed a
feed intake 2.725 Kg when compared to the control group
(2.948 Kg). Also, FCR was found to be 1.741 ± 0.06 when
compared to the control treatment (1.965 ± 0.07). There was
no significant difference in the body weight of FB1-intoxicated
broilers (TOX) when compared to control. Broilers of pre-
colonization treatment (LP and LP+TOX) showed a feed
intake of 2.787 and 2.855 Kg, respectively, when compared
to the TOXB group (2.933 Kg) and showed a FCR ranging
from 1.845 ± 0.27 and 1.860 ± 0.07 when compared to
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TABLE 3 | Effect of L. plantarum MYS6 and fumonisin B1-supplemented feed on
growth performance of broilers after 42 days of feeding experiment.
Groups Body weight (Kg) Feed intake (Kg) FCR Mortality
C 1.509 ± 0.05 2.948 1.965 ± 0.07 0
LP 1.614 ± 0.17 2.787 1.845 ± 0.27 0
TOX 1.575 ± 0.05 2.726 1.741 ± 0.06 0
LP+TOX 1.545 ± 0.06 2.855 1.860 ± 0.07 0
TOX_LP 1.918 ± 0.01a∗ 2.902 1.507 ± 0.00b∗ 0
TOXB 1.659 ± 0.05 2.933 1.777 ± 0.06 0
Data are the mean ± SEM of five broiler birds per treatment group. ∗P < 0.05;
aSignificant when compared to 200 mg toxin control, bSignificant when compared
to TOXB group.
that of TOXB group (1.777 ± 0.06). Our study showed
no significant changes of body weight in the broilers of
treatment groups. The body weight, feed consumption and
FCR of each treatment are tabulated in Table 3. No mortality
was recorded in any of the treatment groups during the
experiment. Broilers fed with FB1 concentration alone, suffered
from dysentery 5 days post toxin treatment (TOX) until the
end of experiment. While the broilers of TOXB group and
challenge study witnessed recurrent episodes of diarrhea during
the experiment. It is important to note that, groups of pre-
colonization study administered with LpMYS6 alone and along
with toxin did not show any signs of illness throughout the
experiment.
Postmortem examination of organs revealed yellowish
discoloration of liver in broilers fed with 200 mg FB1-
contaminated diet, and also witnessed atrophy of liver
(Figure 3i). Further, broilers of other experimental groups
showed dark brown-enlarged liver when compared to normal
sized liver of control group (Figures 3a,e,m,q). The effects
of TOX on relative organs weight are presented in Table 4.
Increase in the mean weight of liver of 3.86 ± 0.16 g/100g
body weight was observed in broilers fed with 200 mg
FB1-contaminated diet (TOX) compared to that of the
control (2.84 ± 0.13 g/100g body weight). With respect to
mean weight of kidney, substantial differences were not
observed in the treatment groups in comparison to the
control.
TABLE 4 | Relative organ weights of control and treatment broilers after 42 days
of feeding experiment.
Relative organ weights (g/100g body weight)
Groups Liver Kidney
C 2.84 ± 0.13 0.08 ± 0.01
LP 3.04 ± 0.35a∗ 0.10 ± 0.00
TOX 3.86 ± 0.16b∗∗ 0.13 ± 0.01
LP+TOX 3.69 ± 0.11 0.11 ± 0.00
TOX_LP 3.20 ± 0.09 0.11 ± 0.00
TOXB 3.61 ± 0.15 0.09 ± 0.03
Data are the mean ± SEM of 5 broiler birds per treatment group. ∗P < 0.05;
aSignificant when compared to toxin control. ∗∗P < 0.01; bSignificant when
compared to control.
Hematological Indices
FB1 toxicity in broilers fed with 200 mg toxin damaged the
hematological parameters. Table 5 summarizes the effects of
FB1 concentration and LpMYS6 on the hematological indices
of broilers. The WBC and PLT count in the control group
were 35420 ± 3860 cells/µL and 12000 ± 700 cells/µL,
respectively. While 200 mg toxin fed broilers showed a
count of WBC up to 40860 ± 850 cells/µL and recorded
9000 ± 410 cells/µL of platelet count. Further, broilers treated
with LpMYS6 alone revealed a lesser count in WBC compared
to all other groups including control. In case of TOXB group,
challenge study and TOX of pre-colonization study, a slight
non-significant increase in WBC count with that of control
was observed revealing no much differences within these
groups. With respect to platelet count, treatment group which
received LpMYS6 alone showed no differences when compared
to control. Additionally, platelet count was slightly reduced
in TOXB group, challenge study and FB1 treatment group
(200 mg) of pre-colonization study when compared to the
control.
Broilers fed with diet containing 200 mg FB1 concentration
alone revealed a reduced (∗P < 0.05) RBC count, hemoglobin
concentration and per cent HCT. Broilers of pre-colonization
study fed with only LpMYS6, TOXB group and challenge study
showed values close to that of control. However, TOX in broilers
pre-colonized with LpMYS6 reestablished the RBC count and
hemoglobin concentration while the per cent HCT remained
unchanged.
Serum Biochemistry
Forty-two days post-feeding, all the biochemical parameters
augmented significantly (P < 0.001) in the serum of broilers
fed with 200 mg FB1 independently compared to control
(Figure 1). SGOT and SGPT, were high in the TOX fed
with 200 mg FB1 only (Figures 1A,B). Treatment with TOXB
also caused a significant increase in the levels of SGOT
(P < 0.001) and SGPT (P < 0.05) when compared to control
(Figures 1A,B). In contrast, the SGOT and SGPT levels were
significantly reduced in the TOX (LP+TOX) of pre-colonization
study administered with LpMYS6. It is notable that, in the
challenge study, LpMYS6 could significantly (P < 0.001)
alleviate the augmented serum levels of SGOT and SGPT
in comparison with TOXB group and pre-colonization study
(Figures 1A,B).
Damage to kidney was assessed by creatinine level and is
depicted in the Figure 1C. Here, an increase in the creatinine
concentration was observed in the TOXB group and 200 mg FB1-
fed groups when compared to the control. In pre-colonization
and challenge study, LpMYS6 significantly (P < 0.001) lowered
the elevated levels of creatinine, however, the reduction level had
no much difference within the treatment groups (Figure 1C).
Broilers fed with FB1 toxin alone showed a significantly
(P < 0.001) high triglyceride, cholesterol and albumin levels
in the serum compared to control (Figures 1D–F). TOXBs
and LpMYS6 each in combination with toxin lowered slightly
the high levels of triglyceride and cholesterol (Figures 1D,E).
While in case of albumin, a significant decline was noted in
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TABLE 5 | Effect of L. plantarum MYS6 and fumonisin B1 supplemented feed on hematological indices of broilers after 42 days of feeding experiment.
Groups WBC103/µL RBC106/µL Hbg/dL HCT% PLT103/µL
C 35.42 ± 3.86 2.25 ± 0.04 9.94 ± 0.18 29.16 ± 1.96 12.0 ± 0.70
LP 33.3 ± 4.85 2.09 ± 0.39 9.1 ± 1.47 28.52 ± 6.03 12.0 ± 1.94
TOX 40.86 ± 0.85 1.52 ± 0.17a∗ 7.16 ± 0.42b∗ 23.6 ± 0.07 9.0 ± 0.41
LP+TOX 38.04 ± 0.97 1.94 ± 0.09 8.40 ± 0.23 24.04 ± 1.06 10.0 ± 0.31
TOX_LP 38.58 ± 1.22 2.07 ± 0.06 9.2 ± 0.08 26.12 ± 0.66 10.0 ± 0.31
TOXB 38.9 ± 1.17 1.9 ± 0.08 8.64 ± 0.30 28.46 ± 3.15 9.2 ± 0.66
Data are the mean ± SEM of five broiler birds per treatment group. ∗P < 0.05; a,bSignificant when compared to control. WBC, white blood cells, RBC, red blood cells,
Hb, hemoglobin, HCT, hematocrit, PLT, platelets.
FIGURE 1 | Effect of fumonisin B1, Lactobacillus plantarum MYS6 and toxin binder (TOXB) on biochemical parameters of control and treatment broilers. The serum
levels of (A) SGOT, (B) SGPT, (C) creatinine, (D) triglycerides, (E) cholesterol, and (F) albumin. Data are the mean ± SEM of five broiler birds per treatment group
and were analyzed using one way ANOWA followed by Bonferroni post hoc test (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001; asignificant when compared to control,
bsignificant when compared to 200 mg FB1 toxin control, csignificant when compared to challenge study).
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broilers of pre-colonization and challenge study in comparison
to TOXB group as well as broilers treated with FB1 alone
(Figure 1F).
Markers of Oxidative Stress
Generation of ROS
Our study demonstrated a significantly high generation of ROS
in liver homogenate and serum of broilers fed with FB1 alone
when compared to the control group. The pre-colonization of
broilers with LpMYS6 remarkably reduced the levels of ROS
in liver homogenate indicating a better result when compared
with the TOXB group (Figure 2A). Also, administering broilers
with LpMYS6 and 200 mg FB1 simultaneously in challenge
study showed a significant (P < 0.01) decline of ROS in liver
homogenate than other TOX groups (Figure 2A). Additionally,
pre-colonization of broilers with LpMYS6 in 200 mg FB1
treatment (LP+TOX) resulted in a notable (P< 0.001) decline of
ROS level in serum. This was less than the ROS of control group
and all the other treatment groups (Figure 2B).
Generation of Hydrogen Peroxide
A substantial elevation of free radical H2O2 was observed in the
liver homogenate (Figure 2C) and serum (Figure 2D) of TOX
group (200 mg FB1) in comparison with control. An equal and
effective reduction by LpMYS6 was observed in H2O2 in the
liver homogenate of pre-colonization and challenge study when
compared to the TOXB group (Figure 2C). However, the levels
of reduction in H2O2 were nonsignificant between the TOXB
group and challenge study. Further, LpMYS6 was more effective
in lowering the elevated levels of H2O2 in the serum samples of
challenge study (TOX_LP) when compared with the LP+TOX
group (200 mg FB1) and TOXB group (TOXB group) at P< 0.001
(Figure 2D).
Lipid Peroxidation
FB1-induced LPO was estimated as an increase in the
concentration of MDA in liver homogenate and serum. In
the FB1-alone-treated broilers, the concentration of MDA in
liver homogenate (Figure 2E) and serum (Figure 2F) were
significantly high compared to the control group. LpMYS6
in pre-colonization study and its co-administration with FB1
in challenge study reduced the levels of MDA both in liver
homogenate (Figure 2E) and serum (Figure 2F) compared to the
TOXB-supplemented group. But the reduction level of MDA in
serum was observed to be non-significant in all the groups.
Protein Oxidation
Carbonyl content generated as a result of protein oxidation
was significantly high in the liver homogenate (Figure 2G)
(P < 0.001) and serum (Figure 2H) (P < 0.01) of broilers treated
with FB1 alone as compared to control group. Compared to
the TOXB, LpMYS6 was more effective in reverting (P < 0.01)
the increased levels of carbonyl content in the liver homogenate
to almost normal state as that of control (Figure 2G). Besides,
LpMYS6 fed broilers of TOX_LP group (challenge study)
significantly brought down the elevated levels of PCC in
serum (Figure 2H). Interestingly, independent administration of
LpMYS6 in LP group showed a slight non-significant increase
in carbonyl content of serum compared to the TOXs of pre-
colonization and challenge studies (Figure 2H).
Histopathology
The histopathological examination substantiated the FB1-
induced toxicity in hepatic and renal parenchyma. The liver
of control group showed a mild irregularity in the hepatocyte
arrangement in hepatic cords (Figures 3b,c). Also, a mild
infiltration of mononuclear cells in the periportal areas and
sinusoidal space were noticed due to aging (Figures 3c,d). The
liver of broilers treated with 200 mg FB1 alone showed severe
disorganization in parenchyma compared to the control group
revealing progressive stages of FB1 toxicity. Severe necrosis and
edema (Figure 3j) of liver parenchyma was conspicuous. Biliary
hyperplasia accompanied with inflammatory cells infiltration
(Figure 3k) was evident of toxin insult. Additionally, liver tissue
manifested extensive fibrosis surrounded by severe mononuclear
cells infiltration suggestive of chronic inflammation (Figure 3l).
Broilers fed with TOXBs showed a lower severity grade
when compared to FB1 alone. Liver tissue of TOXB group
displayed inflammatory cell infiltrates (Figure 3f), disorganized
hepatic cords followed by hepatic necrosis (Figure 3g). Besides,
moderate bile duct proliferation was observed in the liver
of TOXB group (Figure 3h). The liver of broilers treated
with LpMYS6 alone exhibited a mild hepatic disorganization
with mild degeneration and focal to diffused infiltration of
mononuclear cells (Figures 3n–p). However, LpMYS6 effectively
reduced the degree of FB1 toxicity in broilers of pre-colonization
(200 mg FB1 treatment) and challenge study. The liver
displayed normal hepatocytes architecture though a mild to
moderate hepatic disorganization (Figure 3r) was noticed.
Severity of necrosis and edema was considerably attenuated
(Figure 3t). A remarkable reduction in the focal inflammation
and infiltration of mononuclear cells to the sinusoid was
conspicuous (Figure 3s). The liver sections showed no fibrosis
and biliary hyperplasia compared to the TOXB group and FB1
treatment alone.
Kidney sections of control group showed aging morphology
involving normal renal glomeruli and Bowman’s capsule
space (Figure 4a). The increased cellularity of glomeruli
and mild desquamation of tubular epithelium was observed
(Figure 4b). Kidney sections of broilers fed with TOXB
showed severe disruption of tubular epithelium and
accumulation of granular casts in glomeruli (Figure 4c).
Focal inflammation, cellular infiltration and mild edema were
observed in the interstitium accompanied with distal tubular
damage (Figure 4d). While broilers fed with 200 mg FB1
alone exhibited severe desquamation of tubular epithelium
followed by destruction of renal parenchyma. Sections showed
damaged architecture accompanied by acute inflammation with
infiltration of inflammatory cells and massive edema (Figure 4e).
Tubular degeneration proceeded by cytoplasmic vacuolation,
fragmented cytoplasm and tubular lumen filled with eosinophilic
deposits were frequently encountered as the indicators of renal
tubule necrosis (Figure 4f). Besides necrosis, cystic glomeruli
(Figure 4g) and series of renal tubule enlargement involving
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FIGURE 2 | Effect of L. plantarum MYS6 on fumonisin B1 induced oxidative stress in the liver homogenate and serum of control and treatment broilers. In the figure,
(A,B) generation of ROS, (C,D) generation of hydrogen peroxide, (E,F) peroxidation of lipids, and (G,H) oxidation of proteins. Data are the mean ± SEM of five
broiler birds per treatment group and were analyzed using one way ANOWA followed by Bonferroni post hoc test (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001; asignificant
when compared to control, bsignificant when compared to 200 mg FB1 toxin control).
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FIGURE 3 | Morphology and histopathology of hematoxylin-eosin-stained photomicrographs of liver of control and treatment broilers. (a–d) Control, (e–h) TOXB +
200 mg FB1, (i–l) 200 mg FB1 alone, (m–p) L. plantarum MYS6 alone, and (q–t) LpMYS6 + 200 mg FB1. Liver sections were observed at 400× magnification.
granular casts and vacoulation of glomeruli (Figure 4h) were
the other morphologic severity associated with the degeneration
of tissue. In contrary, kidneys of broilers treated with LpMYS6
alone depicted a normal morphology of Bowman’s capsule in
cortex and distal tubules yet age-related mild disruption of renal
parenchyma was noticed (Figures 4i,j). Furthermore, treatment
with LpMYS6 in pre-colonization and challenge study effectively
restored the normal histology of kidney tissues. Renal tubule
regeneration was clearly observed and included an array of
histological changes such as karyomegaly and nuclear crowding
along the affected renal tubules (Figures 4k,l). In addition, the
severity grade of FB1 toxin was extensively reduced and no signs
of edema, necrosis, cystic glomeruli, granular casts or any major
abnormalities in the renal parenchyma were observed.
DISCUSSION
Fumonisin B1-induced deregulation of sphingolipid complex
formation is a well-studied FB1 toxicity in animals and humans.
Unlike most mycotoxins which are cyclic compounds, FB1
is a long-hydroxylated hydrocarbon chain having structural
similarity to the sphingoid bases. FB1 intoxication also manifests
serious consequences of oxidative stress in animals apart from
the inhibition of sphinogolipid metabolism (Poersch et al.,
2014). FB1 is poorly absorbed in the gastrointestinal tract unlike
aflatoxins and is extensively retained as unmetabolized in the
tissues such as liver and kidney. The toxin is eliminated in
bile through enterohepatic recirculation and exerts its toxicity.
It may also end up in the feces and as trace contaminants
in urine (Shephard et al., 1994; Enongene et al., 2000).
Apparently, poultry ingested with FB1 exhibit lack of appetite,
low productive performance, inflamed liver, oral lesions, and
immunosuppression leading to adverse health and economic
status (Poersch et al., 2014). Hence protection against FB1-
induced toxicity and oxidative stress in poultry becomes a
prerequisite.
In our study, we observed a non-significant change in feed
intake and feed conversion in the broilers treated with FB1 alone
compared to control. Previous studies have reported a decrease
in feed intake and feed conversion when broilers, ducks, or
turkeys were ingested with feed contaminated by FB1 (Tessari
et al., 2006; Benlasher et al., 2012). Further, our study showed
no significant variations of body weight in broilers of treatment
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FIGURE 4 | Hematoxylin-eosin stained photomicrographs of kidney of control and treatment broilers. (a,b) Control, (c,d) TOXB + 200 mg FB1, (e–h) 200 mg FB1
alone, (i,j) L. plantarum MYS6 alone, and (k,l) LpMYS6 + 200 mg FB1. Kidney sections were observed at 400× magnification.
groups but health complications such as diarrhea and dysentery
was observed in broilers fed with 200 mg FB1 per Kg feed. Earlier
reports by Tran et al. (2005) and Tardieu et al. (2007) observed a
reduced body weight in ducks and turkeys fed with 0–128 mg of
FB1/Kg feed and 0–20 mg of FB1/Kg feed, respectively. Besides,
increased relative organ weights of liver and kidney in our study
marks FB1 toxicity as these organs are the sites of detoxification
of many toxicants including FB1, and also the target organs for
toxin effects (Voss et al., 2007). Poersch et al. (2014) also reported
a significant increase in the liver weight of broilers treated with
FB1 contaminated feed (100 mg/kg feed) showing its toxicity in
the target organs.
With respect to hematological indices, broilers fed with
200 mg FB1-contaminated feed showed a diminished RBC
count and hemoglobin (P < 0.05). This could be due to the
toxic effects of FB1 on liver leading to haematopoietic (such
as vitamins B12, folic acid, iron) suppression which eventually
results in decreased synthesis of hemoglobin and erythropoietin
and subsequently affect the RBC production and HCT. Our
results are in accordance with the study conducted by Sobrane
Filho et al. (2016), where broilers fed with diet containing a
mixture of aflatoxin B1 (2 mg/kg feed) and FB1 (100 mg/kg
feed) exhibited low values of erythrocyte, hemoglobin, and
hematocrit compared to control while no difference was observed
in the thrombocyte count. Another study by Broomhead et al.
(2002) showed that the above parameters of hematology remain
unaffected in broilers when treated with 25 or 50 mg/kg FB1
in diet. FB1 fed broilers in the present study showed a non-
significant rise in WBC count probably due to an inflammatory
response to the toxin. But Sobrane Filho et al. (2016) reported
a decrease in WBC count in the broilers fed with aflatoxin B1
(2 mg/kg feed) and FB1 (100 mg/kg feed) contaminated diet.
The inconsistency in the hematology results is tempting us to
speculate that hematology would not be a sensitive indicator of
FB1 toxicity in broilers.
Further, increased SGOT and SGPT might be the signs of
damage of hepatocytes and these could be sensitive indicators
of acute hepatic necrosis. In agreement with our results, Khalil
et al. (2015) reported a significant increase in serum liver function
markers such as alanine aminotransferase (ALT), aspartate
aminotransferase (AST), and alkaline phosphatase (ALP) in
Sprague–Dawley rats intoxicated with 100 and 200 mg FB1.
The increased levels of cholesterol and triglyceride in our study
are probable indicators of stress created in broilers due to FB1
feeding affecting lipid metabolism. Also, this could be linked to
decreased feed intake and disruption of sphingolipid metabolism
because of the interrelationships of these pathways. Meanwhile,
a rise in the albumin in FB1-challenged broilers may be due to
the damage of hepatocytes and impairment of protein synthesis.
A study conducted by Cheng et al. (2006) in broilers fed with 5
and/or 15 mg FB1 showed a significant increase in serum AST,
albumin, and cholesterol coupled with poor immunocompetence.
Besides, increased levels of creatinine in the present study could
be the result of protein catabolism or kidney aﬄiction. A previous
study by Khalil et al. (2015) reported a gradual increase in renal
products such as urea, uric acid, and creatinine in rats fed with
200 mg FB1 revealing apparent kidney toxicity. Hence, our results
clearly signify the damaging effects of FB1 on hepatic and renal
tissues.
The FB1 toxicity in broilers was further substantiated by
the assessment of oxidative stress markers in serum and liver
homogenate. The accumulation of free sphingolipid bases due
to FB1 toxicity induces an inhibition of complex 1 of the
mitochondrial respiratory chain, CYP450, and NADPH oxidase
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system and therefore stimulates the generation of diverse ROS
such as superoxide radical, hydrogen peroxide (Domijan and
Abramov, 2011; Mary et al., 2012; Rodrigues and Gomes, 2012).
The ingestion of 200 mg FB1 induced a significant increase in
ROS and H2O2 generation, LPO marker (MDA), and carbonyl
contents of protein oxidation in serum and liver homogenate in
broilers. Recent studies by Theumer et al. (2010) in wistar rats
and Kotan et al. (2011) in human lymphocytes indicated that
generation of ROS and oxidative stress was a direct consequence
of the immunotoxic effects elicited by AFB1 and FB1. Similar
results on oxidative stress were observed in rats treated with
AFB1 and FB1 (Hassan et al., 2014; Abdellatef and Khalil, 2016)
and broiler chicks with FB1 (Poersch et al., 2014). In vivo
studies of Wistar rats treated with 100 mg FB1, documented a
significant increase in MDA level in spleen mononuclear cells,
liver and kidney tissues (Theumer et al., 2010; Hassan et al., 2014).
Apart from lipids, the other possible major target of oxidative
damage is proteins that are further transformed into protein
carbonyls. Mary et al. (2012) proposed that 48 h incubation of
spleen mononuclear cells with 10 µM FB1 significantly raised
the carbonyl content. Also, Domijan et al. (2007) suggested that
200 ng and 50 µg FB1 could cause oxidation of proteins in the
kidney of wistar rats.
The histopathological observations of hepatic and renal tissues
confirmed the abnormal serum biochemistry, oxidative stress
and cellular damage induced by FB1. The intoxicated broilers
marked massive destruction of hepatic and renal tissues. Tessari
et al. (2006) showed severe damage of liver characterized by
disorganization and megalocytosis of hepatocytes, bile duct
proliferation, necrosis and inflammation and kidney sections
displaying hydropic degeneration in broiler chicks exposed to 50
and 200 mg FB1. Further, Voss et al. (2007) proposed that kidney
was the most sensitive organ in Sprague–Dawley and Fischer 344
rats when exposed to FB1, while in BD IX rats, liver was the main
target organ.
Our study demonstrates the protective role of a probiotic
strain, L. plantarum MYS6 (Lp MYS6) against FB1-induced
toxicity and tissue damage. The LpMYS6 strain was previously
characterized in our laboratory for an array of probiotic
attributes, antifungal properties, FB1 detoxification by
binding and extraction/purification of low molecular weight
antifungal compounds (Deepthi et al., 2016). Probiotic LAB
is known to act via diverse mechanisms in vivo which include
modulation of gastrointestinal physiology by increasing the
production of growth factors, competition for nutrients
with enteropathogens, bioconversion of available sugars to
acids, production of vitamins and organic acids, competitive
exclusion for adhesive sites, beneficial immunostimulation
of the gut-associated lymphoid tissue, antioxidative and
anticancer/antiproliferative activities (Alberto et al., 2007;
Oelschlaeger, 2010). Detoxification of mycotoxins by LAB
is mainly mediated by the binding of toxin to bacterial
cell and is dependent on the cell wall structural integrity
of LAB.
In response to probiotic treatment, FB1-challenged broilers
showed significant amelioration of toxin ill effects. Broilers of
pre-colonization study exhibited a gradual increase in feed intake,
body weight and FCR when compared to birds treated with
toxin alone. Moreover, the broilers of challenge study showed
the highest body weight among all treatment groups. Our results
clearly demonstrated that LpMYS6 improved the appetite of
FB1-challenged broilers thereby increasing the feed intake and
body weight. A recent study by Khalil et al. (2015), reported
that L. delbrueckii subsp. lactis and Pediococcus acidilactici
significantly helped in improving the body weight and feed intake
of rats after three weeks of exposure to 50, 100, and 200 mg
concentrations of FB1. Also, our results are in line with the work
by Gratz et al. (2006), who demonstrated that L. rhamnosus strain
GG improved the body weight gain in rats intoxicated with AFB1.
LpMYS6 was efficient in reducing the toxicity-induced weight
gain in the liver, but there was no significant effect on the relative
weight of kidney in all the dietary treatments. With respect to
hematological parameters, LpMYS6 efficiently reestablished the
RBC count and hemoglobin. The elevated levels of WBC and
reduced count of PLT were restored by LpMYS6 administration.
Jiang et al. (2014) showed that supplementation of yeast cell wall
absorbent had a protective effect on WBC, lymphocytes, PLT, and
hemoglobin in broilers fed with mycotoxin-contaminated feed.
Further, oral administration of LpMYS6 significantly restored
the altered levels of serum parameters such as SGOT, SGPT,
creatinine, cholesterol, triglycerides and albumin, both in the
pre-colonization and challenge study. The alleviated level of
SGPT specifically indicates the rehabilitation of hepatocytes, and
also the serum cholesterol. The reduction in elevated levels
of cholesterol by LpMYS6 indicate normal lipid metabolism
including sphingolipid formation and normalized feed intake.
High serum creatinine is an indication of renal trauma. Our
strain, LpMYS6 was efficient in reducing creatinine level which
may be due to proper catabolism of dietary/tissue proteins
and filtration rate in kidney. The above results indicate
that LpMYS6 effectively reduced the FB1-induced hepatorenal
toxicity. Khalil et al. (2015) reported that co-administration
of L. delbrueckii subsp. lactis and Pediococcus acidilactici was
efficient in normalizing ALT, AST, albumin, bilirubin levels in
rats fed with 200 mg FB1-contaminated diet. Also, Jiang et al.
(2014) studied that supplementation of yeast cell wall absorbent
to the mycotoxin contaminated diet could significantly improve
the serum levels of AST, ALT, ALP, and GGT in broiler chickens.
Furthermore, LpMYS6 effectively scavenged the elevated ROS
and H2O2 in serum and liver homogenate. Also, the probiotic
strain remarkably stabilized the altered levels of LPO and PCC
in serum and tissue homogenate of liver. Administration of
LpMYS6 was observed to significantly reinstate the normal
morphology of liver and kidney. Deabes et al. (2012) reported
a significant reduction of oxidative status in liver and kidney
of aflatoxin-challenged mice treated with L. rhamnosus starin
GG by increasing the contents of reduced glutathione (GSH)
and superoxide dismutase (SOD). Further, a study by Abdellatef
and Khalil (2016), demonstrated the ameliorative effects of
L. delbureckii subsp. lactis DSM 20076 and Pediococcus
acidilactici NNRL B-5627 on fumonisin B1-induced hepatoxicity
and nephrotoxicity in rats.
LpMYS6 induces its protective effects probably by binding FB1
in the chicken crop or gastrointestinal tract and consequently
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reducing the bioavailability of FB1. This is supported by
our previous observation on the in vitro binding ability of
L. plantarum MYS6 to FB1 toxin wherein the per cent removal
of FB1 was 32.9% and 61.7% in 2 and 4 h of incubation time,
respectively (Deepthi et al., 2016). Several studies suggest that
binding is the main mechanism of detoxification of mycotoxins
by LAB (Gratz et al., 2007; Hathout et al., 2011; Abbes et al., 2016;
Abdellatef and Khalil, 2016). However, the binding mechanism
itself is not thoroughly understood. Zoghi et al. (2014) reported
that probiotic LAB binds to the toxin due to the adhesive nature
of S-layer proteins in their cell wall. Shetty and Jespersen (2006)
suggested that carbohydrate-rich mannoproteins or glucans of
LAB are involved in their binding to mycotoxins. Recently,
Huang et al. (2017) suggested that L. plantarum C88 could
effectively detoxify aflatoxin by suppressing the expression of
cytochrome P450 1A2 and CYP 3A4 to decrease the production
of AFBO (exo-AFB1-8,9-epoxide) and activate GST A3 through
Nrf2 signaling pathways. This in turn improves GSH-conjugating
activity and reduces toxin mediated oxidative stress. The majority
of studies on detoxification of mycotoxins by LAB are aflatoxin-
oriented with very limited data existing for LAB-mediated
amelioration of FB1-induced toxicity and oxidative stress in
broilers. In this context, we made an attempt to evaluate the
protective effects of a potent probiotic strain, L. plantarum MYS6
against FB1 toxicity and oxidative stress in broilers. Our results
showed that protective effects of LpMYS6 were significantly high
in challenge study when compared to pre-colonization study.
This indicates that the binding of FB1 occurs immediately after
administration of LpMYS6 and pre-colonization of LpMYS6
might delay or decrease the binding process. Our outcome
is in line with a recent finding by Huang et al. (2017) who
reported that L. plantarum C88 effectively binds to AFB1 within
2 h post dose in mice and excreted in high levels as fecal
AFB1 and lactobacilli. Nevertheless, systemic studies are still
needed to understand the precise binding mechanism of FB1
to LAB.
Toxin binders are inert indigestible adsorbents widely
employed in the poultry feed industry as detoxicification method.
Several studies are available suggesting the application of TOXBs
such as HSCAS, clay products, bentonites, zeolites, activated
carbon etc (Huwig et al., 2001; Galvano et al., 2001; Avantaggiato
et al., 2004; Kabak et al., 2006; Jouany, 2007; Phillips et al., 2008;
Devreese et al., 2013; Agboola et al., 2015) as an effective method
to minimize mycotoxin-induced toxicity. Interestingly, we found
that TOXB was less effective in sequestering the toxin. Moreover,
they seemed to induce oxidative stress and organ damage to some
extent in our study.
In summary, the present investigation clearly demonstrates
the FB1-induced toxicity, oxidative stress and vital organ damage
in broilers. Oral administration of L. plantarum MYS6 to broilers
significantly mitigated the FB1-induced toxicity and organ
damage. L. plantarum MYS6 also significantly reinstated the
imbalanced serum biochemical parameters, oxidative markers
and hepatic and renal tissue damage. L. plantarum MYS6 was
more effective in sequestering the toxin when compared to the
commercially available TOXB and had protective health benefits.
The protective role of L. plantarum MYS6 may be due to its
FB1-binding capacity thereby reducing the toxin bioavailability
in broilers. To the best of our knowledge, the present study
is the first of its kind in employing a probiotic lactic acid
bacterium to reduce the effects of FB1-induced oxidative stress
and organ damage in broilers. The future prospect of the study
is to understand the changes in gut microbiota, mechanism
of interaction between LAB and FB1 at molecular level and
developing a functional probiotic feed for broilers.
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